Details
Travinor Indications
To reduce high intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Contradictions
Hypersensitivity to the active substance or to other components of the medicinal product.
Dosage & Administration
For ophthalmic use.
Use for the treatment of adults, including the elderly
1 drop of Travinor® in the conjunctival sac (bags) of the affected eye (s) once a day. The optimal effect is achieved by administering the dose in the evening.
After instillation, it is recommended to clamp the nasolacrimal duct or slightly close the eyelids. This reduces the systemic absorption of drugs administered to the eye, which may reduce the likelihood of systemic side effects.
If more than one topical ophthalmic agent is used, the interval between their application should be at least 5 minutes.
If a dose is missed, treatment should be continued from the next scheduled dose. The dose should not exceed one drop in the affected eye (s) once a day.
If another ophthalmic antiglaucoma agent is replaced with Travinor, the other drug should be discontinued and Travinor should be started the next day.
Use in disorders of the liver and kidneys
Travoprost has been studied in patients with hepatic impairment (mild to severe) and in patients with renal impairment (mild to severe) (creatinine clearance below 14 ml / min). There is no need to adjust the dose for such patients (see section "Pharmacological properties").
For patients who wear contact lenses, see section "Features of application".
To prevent contamination of the dropper edge and the contents of the vial, be careful not to touch the eyelids, adjacent areas or other surfaces with the edge of the dropper vial.
Children. Efficacy and safety of the drug in patients under 18 years of age have not been established, so its appointment in patients of this group is not recommended until the relevant data.
